Aquestive Therapeutics Inc. (AQST) at a glance

Aquestive Therapeutics Inc. (AQST) is a small-cap Healthcare company. It trades at $5.05, with a -137.1% profit margin and revenue growth of 65.7%. It does not pay a dividend. Vestovix scores it 55/100 overall. Its strongest dimension is Growth (94/100) and its weakest is Value (40/100). It carries above-market volatility, so expect larger swings.

Price

$5.05

Market cap

$523.1M

P/E ratio

n/a

Dividend yield

None

Beta

1.45

52-week range

$2.93 to $7.55